Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction

Key Inclusion Criteria: * Acute myocardial infarction (AMI) * Clinical symptoms consistent with AMI for a minimum of 2 and a maximum of 12 hours from onset of symptoms to Percutaneous Coronary Intervention (PCI), and unresponsive to nitroglycerin * Successful revascularization of the culprit lesion in the major epicardial vessel * Area of hypo- or akinesia corresponding to the culprit lesion, as determined by left ventriculogram at the time of primary PCI * Left ventricular ejection fraction (LVEF) ≥30% and ≤50% by Left Ventricular Angiography at the time of successful revascularization. * Ability to undergo liposuction Key Exclusion Criteria: * Prior MI, prior known cardiomyopathy, or prior hospital admission for congestive heart failure (CHF) * More than 24 hours after acute PCI * Significant valvular disease * More than twelve hours between the onset of first symptoms of AMI and revascularization * Hemodynamic instability within 24 hours prior to randomization * Neoplasia * Acute or chronic bacterial or viral infectious disease * Pacemaker, ICD or any other contra-indication for MRI * LVEF \<30% or \>50% by Left Ventricular Angiography * Moderate or severe COPD